US Patent 8163287 Combination therapy of her expressing tumors
Patent 8163287 was granted and assigned to Genentech on April, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+135 characters)
Article
Patent abstract
The invention relates to tumors expressing HER2 and EGFR, using HER2-dimerization inhibitors (HDIs) and EGFR inhibitors.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Mark X. Sliwkowski0
Stephen M. Kelsey0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08163287 Combination therapy of her expressing tumors US Patent 8163287 Combination therapy of her expressing tumors
Infobox
Patent Number
081632870
Patent Number
81632870
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081632870
Date of Patent
April 24, 2012
0Patent Application Number
114904380
Date Filed
July 19, 2006
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08163287 Combination therapy of her expressing tumors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08163287
Date of patent
April 24, 2012
Patent application number
11490438
Date Filed
July 19, 2006
Patent primary examiner
Find more entities like US Patent 8163287 Combination therapy of her expressing tumors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
